CSX
CLEANSPACE FPO [CSX]
Healthcare · ASX Small Cap
$0.5300 +6.0%
Updated 7 Mar 2026 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score -4First seen: 2026-03-02
Score Breakdown
Technical49
Catalyst50
Sentiment50
Fundamental91
Momentum59
Risk Gate40
Active Signals
Bullish Signals
- RSI approaching oversold
- Sustained volume spike (6.6x median) on UP trend
- Underperforming ASX Small Ords (RS 0.89)
- Cash positive / operating cashflow positive
- Low P/S ratio (2.1x)
- Moderate revenue growth (+10%)
- Piotroski F-Score strong (8/9, low-confidence approx)
- EPS estimates revised upward (+10pts)
- Small-cap ($20-100M)
- CANSLIM I: Institutional ownership (34%)
- Positive 12-1 momentum (+46%)
- Liquidity risk: 6 zero-volume days in last 20
- RBA hiking (-3pts)
Risk Signals
- Price below MAs (downtrend)
- Below 200-day MA (long-term downtrend)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
- Volume-weighted momentum negative (-0.71%/day)
- Overseas neutral (-3pts, S&P500 neutral, VIX 27)
Recent Catalysts
NONE Application for quotation of securities - CSX
NONE H1 FY26 Results Presentation
NONE H1 FY26 Results
Recent ASX Announcements
| 2026-03-02 | Application for quotation of securities - CSX |
| 2026-02-25 | H1 FY26 Results Presentation |
| 2026-02-25 | H1 FY26 Results PRICE SENSITIVE |
| 2026-02-25 | Appendix 4D and Interim Report PRICE SENSITIVE |
| 2026-02-23 | CleanSpace Receives $891k R&D Cash Rebate |
Key Metrics
$43.6M
Market Cap
12K
Avg Volume
6.6x
Vol Ratio
$0.37 — $0.88
52-Week Range
N/A
Short Interest
N/A
Cash Runway
8.8%
ROE
8.5%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | neutral | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 59% |
| L | Leader vs Laggard | laggard | RS: -10 |
| I | Institutional Sponsorship | pass | Inst: 34% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
Ranked #79 of 122 · Sector avg: 43
View all Healthcare signals →